The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Issue of Equity

24 Apr 2018 16:52

RNS Number : 9903L
Maven Income & Growth VCT 4 PLC
24 April 2018
 

Maven Income and Growth VCT 4 PLC (the Company)

 

Issue of Equity

 

The Board of the Company is pleased to announce that, up to 12.00 noon on 20 April 2018 (the final deadline for the receipt of applications), the Company received (and subsequently accepted) valid applications to the value of £20 million, including an over allotment facility of £5 million, for its offer for subscription that opened on 22 September 2017 (the Offer). The Offer is now closed to further applications.

 

Pursuant to the Offer, and the £2,758,192.58 of valid applications received in respect of the 2018/2019 tax year, the Company has issued and allotted 3,513,830 new Ordinary Shares on 24 April 2018. In accordance with the allotment formula set out in the prospectus for the Offer, the offer prices at which the shares were issued were in the range of 77.85p to 79.87p per Ordinary Share.

 

In respect of this allotment, an application will be made by the Company to the UK Listing Authority and to the London Stock Exchange for the new Ordinary Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the new Ordinary Shares will become effective and dealings will commence on or around 26 April 2018.

 

Following this final allotment, a total of 24,595,907 Ordinary Shares have been issued by the Company pursuant to the Offer, and the number of Ordinary Shares now in issue is 57,346,600. Therefore, the total number of voting rights in the Company is 57,346,600.

 

The above statement of Voting Capital may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Secretary

 

24 April 2018

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEPGUUACUPRGAC

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.